Streptococcal Infections Clinical Trial
Official title:
Rapid Strep Testing in Children With Recent Streptococcal Pharyngitis
The purpose of this study is to determine if the rapid antigen detection test for Group A streptococcal pharyngitis diagnosis might yield higher rates of false positive results in patients who have been treated for GAS pharyngitis within 28 days of the test.
Strep pharyngitis, or strep throat, is a common infection afflicting children, aged 2 and
above. Testing for strep pharyngitis consists of a rapid test and/or a throat culture.
However, it has been observed that rapid testing may not be accurate in children with a
recent history of strep pharyngitis. Therefore, this study aims to determine the accuracy of
rapid strep testing in children who are presenting with symptoms of strep throat, who also
have a recent history of and treatment for strep pharyngitis. By demonstrating an inaccuracy
in rapid strep testing in patients with a recent history of strep pharyngitis, unnecessary
testing and antibiotic use may be decreased, thereby reducing costs, overuse of antibiotics,
and antibiotic resistance.
The participants in the study will include 600 children, aged 2 to 20 years old, selected
from a private practice in Northern Virginia who present to the practice with signs or
symptoms suggestive of acute pharyngitis. Subjects are children who are presenting with signs
and symptoms suggestive of acute pharyngitis by the Centor criteria, including sore throat,
fever, abdominal pain and cervical lymphadenitis. Any child with above presenting symptoms
who is to undergo Streptococcus rapid antigen testing will be recruited to participate in the
study.
A letter of consent will be provided to the parents and guardians of the involved child,
stating that the study will be voluntary and confidential, and that all results will be kept
in a safe environment.
Investigators will be testing the difference between two proportions, the false positive rate
in previously treated compared to those not treated.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02052973 -
Efficacy of Propolis Varnish Against Oral Biofilm
|
Phase 1/Phase 2 | |
| Completed |
NCT01412801 -
Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings
|
Phase 2 | |
| Completed |
NCT00884728 -
Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territory
|
N/A | |
| Completed |
NCT01193920 -
Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non Pregnant and Pregnant Women 18-40 Years of Age
|
Phase 1/Phase 2 | |
| Terminated |
NCT00261742 -
Comparative Trial of Oral Penicillin Versus Cefuroxim for Treatment of Perianal Streptococcal Dermatitis
|
Phase 4 | |
| Completed |
NCT00169481 -
A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate Vaccine
|
Phase 2 | |
| Completed |
NCT02270944 -
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine
|
Phase 2 | |
| Withdrawn |
NCT00598429 -
Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failure
|
Phase 2 | |
| Completed |
NCT01030731 -
Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease
|
Phase 1 | |
| Completed |
NCT04100772 -
Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above
|
Phase 1 | |
| Completed |
NCT01118143 -
Oral Health Literacy Tailored Communication
|
N/A | |
| Completed |
NCT01026740 -
Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers
|
Phase 1 | |
| Withdrawn |
NCT00330642 -
Rapid Detection of Group B Streptococcus (Strep)-Labor and Delivery Study
|
N/A | |
| Completed |
NCT00299663 -
Long Term Follow-up of Patients With Group A Streptococcal Infection Originating From the Genital Tract
|
N/A | |
| Completed |
NCT00646958 -
Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections
|
Phase 2 | |
| Completed |
NCT01026636 -
A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age
|
Phase 1 | |
| Completed |
NCT00514527 -
A Study for Patients With Complicated Skin and Skin Structure Infections
|
Phase 2 | |
| Completed |
NCT01026558 -
A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients
|
Phase 1 | |
| Completed |
NCT01156740 -
Treatment of Group A Beta Hemolytic Streptococcal Pharyngitis in Children in Low Resource Settings
|
N/A | |
| Completed |
NCT04841369 -
Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)
|
Phase 3 |